On March 30, 2020, Robert Rankin, the Chief Financial Officer, Secretary and Treasurer of Hancock Jaffe Laboratories, Inc. resigned.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | 0.00% | -1.96% | -2.72% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.72% | 66.65M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- NVNO Stock
- News enVVeno Medical Corporation
- Hancock Jaffe Laboratories, Inc. Announces Resignation of Robert Rankin as Chief Financial Officer, Secretary and Treasurer